Norges Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-55,000
| Closed | -$2.11M | – | 664 |
|
|
2025
Q2 | $2.11M | Buy |
+55,000
| New | +$2.1M | ﹤0.01% | 1428 |
|
|
2023
Q3 | – | Sell |
-189,999
| Closed | -$6.77M | – | 1998 |
|
|
2023
Q2 | $6.77M | Buy |
189,999
+37,000
| +24% | +$1.33M | ﹤0.01% | 1643 |
|
|
2023
Q1 | $5.44M | Hold |
152,999
| – | – | ﹤0.01% | 1730 |
|
|
2022
Q4 | $5.38M | Sell |
152,999
-60,001
| -28% | -$2M | ﹤0.01% | 1762 |
|
|
2022
Q3 | $6.27M | Buy |
+213,000
| New | +$8.07M | ﹤0.01% | 1689 |
|
|
2021
Q1 | – | Sell |
-602,982
| Closed | -$27.7M | – | 2156 |
|
|
2020
Q4 | $27.7M | Buy |
602,982
+135,418
| +29% | +$6.22M | 0.01% | 1372 |
|
|
2020
Q3 | $22M | Sell |
467,564
-250,324
| -35% | -$12.5M | 0.01% | 1361 |
|
|
2020
Q2 | $36.6M | Hold |
717,888
| – | – | 0.01% | 1051 |
|
|
2020
Q1 | $34M | Buy |
717,888
+181,083
| +34% | +$9.66M | 0.01% | 908 |
|
|
2019
Q4 | $31.5M | Buy |
536,805
+72,287
| +16% | +$4.02M | 0.01% | 1229 |
|
|
2019
Q3 | $24.8M | Sell |
464,518
-38,434
| -8% | -$1.98M | 0.01% | 1353 |
|
|
2019
Q2 | $25.2M | Buy |
502,952
+141,275
| +39% | +$7.09M | 0.01% | 1361 |
|
|
2019
Q1 | $18.9M | Hold |
361,677
| – | – | 0.01% | 1540 |
|
|
2018
Q4 | $17.3M | Hold |
361,677
| – | – | 0.01% | 1488 |
|
|
2018
Q3 | $18.2M | Buy |
361,677
+77,595
| +27% | +$3.94M | 0.01% | 1586 |
|
|
2018
Q2 | $14.3M | Hold |
284,082
| – | – | ﹤0.01% | 1689 |
|
|
2018
Q1 | $13.9M | Hold |
284,082
| – | – | 0.01% | 1628 |
|
|
2017
Q4 | $12.6M | Sell |
284,082
-114,909
| -29% | -$5.31M | ﹤0.01% | 1659 |
|
|
2017
Q3 | $20.2M | Hold |
398,991
| – | – | 0.01% | 1437 |
|
|
2017
Q2 | $21.5M | Hold |
398,991
| – | – | 0.01% | 1363 |
|
|
2017
Q1 | $21M | Hold |
398,991
| – | – | 0.01% | 1357 |
|
|
2016
Q4 | $19.2M | Hold |
398,991
| – | – | 0.01% | 1338 |
|
|
2016
Q3 | $20.5M | Hold |
398,991
| – | – | 0.01% | 1233 |
|
|
2016
Q2 | $21.6M | Hold |
398,991
| – | – | 0.01% | 1158 |
|
|
2016
Q1 | $20.2M | Hold |
398,991
| – | – | 0.01% | 1152 |
|
|
2015
Q4 | $20.1M | Hold |
398,991
| – | – | 0.01% | 1157 |
|
|
2015
Q3 | $19.2M | Sell |
398,991
-377,761
| -49% | -$19.7M | 0.01% | 1154 |
|
|
2015
Q2 | $40.4M | Hold |
776,752
| – | – | 0.02% | 760 |
|
|
2015
Q1 | $44.8M | Hold |
776,752
| – | – | 0.02% | 702 |
|
|
2014
Q4 | $41.5M | Hold |
776,752
| – | – | 0.02% | 728 |
|
|
2014
Q3 | $44.6M | Sell |
776,752
-776,752
| -50% | -$47.6M | 0.02% | 668 |
|
|
2014
Q2 | $104M | Buy |
1,553,504
+776,752
| +100% | +$52.6M | 0.03% | 604 |
|
|
2014
Q1 | $51.9M | Hold |
776,752
| – | – | 0.03% | 561 |
|
|
2013
Q4 | $51.8M | Hold |
776,752
| – | – | 0.03% | 547 |
|
|
2013
Q3 | $48.7M | Hold |
776,752
| – | – | 0.03% | 587 |
|
|
2013
Q2 | $48.5M | Buy |
+776,752
| New | +$49.3M | 0.03% | 536 |
|
Other funds holding GSK
JEST
Norges Bank's GSK Position: Q3 2025 in Review
Norges Bank sold out of GSK (GSK) in Q3 2025, closing a stake of 55,000 shares — an estimated $2.11M sold.
Norges Bank first reported a position in GSK in Q2 2013 and held it in 36 quarters. The position peaked at $104M in Q2 2014. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.
- Norges Bank reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
- Norges Bank sold 55,000 GSK shares in Q3 2025, an estimated $2.11M.
- Norges Bank first reported a position in GSK in Q2 2013 and held it in 36 quarters.
- Norges Bank's GSK position peaked at $104M in Q2 2014.
- 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.
Based on Norges Bank's 13F filing for Q3 2025.